Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Cardiology

Clinical Pharmacology

Creatinine rise during blood pressure therapy and the risk of adverse clinical outcomes in patients with type 2 diabetes mellitus: A post hoc analysis of the ACCORD-BP randomized controlled trial

Hypertension | Nov 23, 2018 Clinical Pharmacology

High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] study)

Metabolism | Nov 22, 2018 Clinical Pharmacology

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): An open-label, pilot, randomised trial

The Lancet | Nov 17, 2018 Clinical Pharmacology

Angiotensin–neprilysin inhibition in acute decompensated heart failure

New England Journal of Medicine | Nov 16, 2018 Clinical Pharmacology

Dapagliflozin and cardiovascular outcomes in type 2 diabetes

New England Journal of Medicine | Nov 15, 2018 Clinical Pharmacology

Low-dose methotrexate for the prevention of atherosclerotic events

New England Journal of Medicine | Nov 15, 2018 Clinical Pharmacology

Alirocumab and cardiovascular outcomes after acute coronary syndrome

New England Journal of Medicine | Nov 13, 2018 Clinical Pharmacology

Longer-term lipid-lowering drug use and risk of incident and fatal prostate cancer in black and white men in the ARIC Study

Cancer Prevention Research | Nov 10, 2018 Clinical Pharmacology

Prognostic significance, angiographic characteristics and impact of antithrombotic and anticoagulant therapy on outcomes in high vs low grade coronary artery ectasia: A long-term follow-up study

Catheterization and Cardiovascular Interventions | Nov 08, 2018 Clinical Pharmacology

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: An exploratory analysis of the ELIXA randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology | Nov 08, 2018 Clinical Pharmacology

« Prev 1 … 124 125 126 127 128 … 163 Next »

Creatinine rise during blood pressure therapy and the risk of adverse clinical outcomes in patients with type 2 diabetes mellitus: A post hoc analysis of the ACCORD-BP randomized controlled trial

High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] study)

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): An open-label, pilot, randomised trial

Angiotensin–neprilysin inhibition in acute decompensated heart failure

Dapagliflozin and cardiovascular outcomes in type 2 diabetes

Low-dose methotrexate for the prevention of atherosclerotic events

Alirocumab and cardiovascular outcomes after acute coronary syndrome

Longer-term lipid-lowering drug use and risk of incident and fatal prostate cancer in black and white men in the ARIC Study

Prognostic significance, angiographic characteristics and impact of antithrombotic and anticoagulant therapy on outcomes in high vs low grade coronary artery ectasia: A long-term follow-up study

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: An exploratory analysis of the ELIXA randomised, placebo-controlled trial

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Artice: Adult Vaccination Updates Every Family Doctor Should Know

Article: Clinical Guide to Molecular Testing in Bethesda III and IV Nodules for Indian Practice

New research aims to transform treatments of aggressive blood cancer

Creatinine rise during blood pressure therapy and the risk of adverse clinical outcomes in patients with type 2 diabetes mellitus: A post hoc analysis of the ACCORD-BP randomized controlled trial

High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] study)

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): An open-label, pilot, randomised trial

Angiotensin–neprilysin inhibition in acute decompensated heart failure

Dapagliflozin and cardiovascular outcomes in type 2 diabetes

Low-dose methotrexate for the prevention of atherosclerotic events

Alirocumab and cardiovascular outcomes after acute coronary syndrome

Longer-term lipid-lowering drug use and risk of incident and fatal prostate cancer in black and white men in the ARIC Study

Prognostic significance, angiographic characteristics and impact of antithrombotic and anticoagulant therapy on outcomes in high vs low grade coronary artery ectasia: A long-term follow-up study

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: An exploratory analysis of the ELIXA randomised, placebo-controlled trial

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Artice: Adult Vaccination Updates Every Family Doctor Should Know

Article: Clinical Guide to Molecular Testing in Bethesda III and IV Nodules for Indian Practice

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic